Redding, California, Sept. 18, 2023 (GLOBE NEWSWIRE) -- According to a new market research report, ‘Europe Pharmaceutical Contract Development and Manufacturing Market by Service {Manufacturing [API, FDF (Parenteral, Tablet, Capsule, Oral Liquid)], Drug Development, Biologics Manufacturing, Packaging}, End User [Large Pharma, Generic] —Forecast to 2030’, published by Meticulous Research®, the Europe pharmaceutical contract development and manufacturing market is expected to reach $68.12 billion by 2030 at a CAGR of 7.4% from 2023 to 2030.
Pharmaceutical contract development and manufacturing organizations (CDMOs) partner with pharmaceutical companies and offer contract-based manufacturing and drug development services. CDMOs handle everything from pre-formulation and formulation development to clinical trials and manufacturing. Pharmaceutical companies opt for CDMOs because of the benefits such as reduced labor, cost, high product quality, faster time, and resource savings.
The growth of the Europe pharmaceutical contract development and manufacturing market is attributed to the complex manufacturing requirements of the pharmaceutical industry, manufacturers’ growing inclination toward the use of cutting-edge technologies, patent expiration, increasing investments in pharmaceutical R&D, and the rising demand for generic medicines & biologics. However, the lack of skilled professionals is challenging the growth of this market. In addition, growing consolidation among CDMO market players and virtual business models are the industry trends in the market.
Download Free Report Sample Now: https://www.meticulousresearch.com/download-sample-report/cp_id=5592
Rising Demand for Generic Medicines and Biologics
The increasing prevalence of cancer and autoimmune, cardiovascular, and infectious diseases in Europe has resulted in the emergence of biopharmaceuticals or biologics as an important therapeutic class for treating these diseases. Biologics offer numerous advantages over synthetic drugs by targeting specific sites and rarely causing side effects. This results in increasing approvals and the demand for biologics, such as therapeutic proteins and monoclonal antibodies (MAbs).
According to Eurostat, 35.2% of Europeans reported suffering from chronic illnesses in 2021. Furthermore, the COVID-19 pandemic and the rising incidences of infectious diseases significantly burdened the healthcare sector and boosted the demand for vaccines. Due to this, the demand for biopharmaceutical products has risen with the subsequent growth in the Europe pharmaceutical contract development and manufacturing market.
The report includes an extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past years (2020–2023). The key players operating in the Europe pharmaceutical contract development and manufacturing market are AbbVie Inc.(U.S.), Aenova Group (Germany), Wuxi Biologics, Inc. (China), Vetter Pharma International GmbH (Germany), Catalent, Inc. (U.S.), Lonza Group Ltd. (Switzerland), Recipharm AB (Sweden), Almac Group (U.K.), C.H. Boehringer Sohn Ag & Co. KG. (Germany), Eurofins Scientific (France), Curia Global, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Evonik Industries AG (Germany), Cambrex Corporation (U.S.), Siegfried Holdings AG (Switzerland), Fabbrica Italiana Sintetici S.p.A. (Italy), and Corden Pharma GmbH (Germany).
Have Any Query? Ask To Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5592
The Europe pharmaceutical contract development and manufacturing market study presents historical market data in terms of values (2021 and 2022), estimated current data (2023), and forecasts it for 2030.
Pharmaceutical Contract Development and Manufacturing Market by Type (Pharmaceutical Manufacturing Services {Active Pharmaceutical Ingredient (API) Manufacturing Services and Finished Dosage Forms (FDF) Manufacturing Services [Parenteral/Injectable Manufacturing Services, Tablet Manufacturing Services, Capsule Manufacturing Services, Oral Liquid Manufacturing Services, and Other Formulations]}, Drug Development Services, and Biologics Manufacturing Services {Active Pharmaceutical Ingredient (API) Manufacturing Services and Finished Dosage Forms (FDF) Manufacturing Services}), End User (Large Pharmaceutical Companies, Small & Mid-Size Pharmaceutical Companies, and Generic Pharmaceutical Companies), and Countries. The study also evaluates industry competitors and analyzes their market share at the country level.
Among all types studied in this report, the biologics manufacturing services segment is expected to grow at the highest CAGR during the forecast period. The growth of the biologics manufacturing services segment is driven by the growing inclination of biopharma and pharma companies towards outsourcing their activities to accelerate drug development workflow and the growth in the adoption of advanced technologies for biologics production. The increasing number of developments in the sector has resulted in pharmaceutical and biopharmaceutical companies outsourcing their manufacturing function to CDMOs.
Additionally, the increasing prevalence of chronic diseases, the increasing advantages of biologics over synthetic drugs, and the demand & approvals for biologics support market growth. Biologics are used for diabetes management, and Victoza and Trulicity are used for diabetes treatment. For instance, according to the International Diabetes Federation, in Europe, the number of people with diabetes is expected to reach 67,000 in 2030 from 61,425 in 2021.
Quick Buy – Europe Pharmaceutical Contract Development and Manufacturing Market - Opportunity Analysis and Industry Forecast (2023-2030), Research Report: https://www.meticulousresearch.com/Checkout/41245836
Among all end users studied in this report, in 2023, the large pharmaceutical companies segment is expected to account for the largest share of the market. Factors such as the increasing need for cost control amid increasing pricing pressure, complex manufacturing requirements, and inclination towards cutting-edge technologies contribute to the market's largest share. Factors such as increasing competition in the generic market leading to pricing pressure and the growing inclination of these companies toward the use of cutting-edge technologies offered by contract development and manufacturing companies are also driving the market. Additionally, generic pharmaceutical companies typically rely on contract development & manufacturing firms for high-quality manufacturing, packaging, and distribution services of generic APIs and intermediates across various countries, increasing their geographic reach.
Among all the countries studied in this report, in 2023, Germany is expected to account for the largest share of the Europe pharmaceutical contract development and manufacturing market. The large market share of the country is attributed to the favorable environment for developing and producing research-intensive, high-grade products. In addition, according to the World Bank, health expenditure in Germany increased from 10.7% in 2011 to 12.5% in 2020. This increase indicates the high focus of the country on its healthcare infrastructure, making it a suitable location for research that expands the drug pipeline.
To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/europe-pharmaceutical-contract-development-and-manufacturing-market-5592
Scope of the Report:
Europe Pharmaceutical Contract Development and Manufacturing Market Assessment—by Type
- Pharmaceutical Manufacturing Services
- Active Pharmaceutical Ingredient (API) Manufacturing Services
- Finished Dosage Forms (FDF) Manufacturing Services
- Parenteral/Injectable Manufacturing Services
- Tablet Manufacturing Services
- Capsule Manufacturing Services
- Oral Liquid Manufacturing Services
- Other Formulations
- Drug Development Services
- Biologics Manufacturing Services
- Active Pharmaceutical Ingredient (API) Manufacturing Services
- Finished Dosage Forms (FDF) Manufacturing Services
(Other formulations include Topical Formulations, Powders Formulations, and Modified-Release Dosage Forms)
Europe Pharmaceutical Contract Development and Manufacturing Market Assessment—by End User
- Large Pharmaceutical Companies
- Small & Mid-Size Pharmaceutical Companies
- Generic Pharmaceutical Companies
Europe Pharmaceutical Contract Development and Manufacturing Market Assessment —by Country
- Germany
- U.K.
- France
- Italy
- Spain
- Switzerland
- Netherland
- Denmark
- Rest of Europe
Request Free Report Sample Now: https://www.meticulousresearch.com/request-sample-report/cp_id=5592
Related Reports:
Pharmaceutical Contract Development & Manufacturing Market by Service {Manufacturing [API, FDF (Parenteral, Injectable, Tablet, Capsule, Oral Liquid)], Drug Development, Biologics Manufacturing}, End User [Large Pharma, Generic] - Global Forecast to 2029
Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market By Service {Manufacturing [API, FDF (Parenteral, Tablet, Capsule, Oral Liquid)], Drug Development, Biologics Manufacturing, Packaging}, End User [Large Pharma] - Forecast to 2030
Pharmaceutical Contract Packaging Market by Service (Primary Packaging {Bottle, Vial, Ampoules, Blister Packs}, Secondary Packaging), Material (Plastic, Polymer, Paper, Glass, Aluminum Foil), and Geography - Global Forecast to 2029
https://www.meticulousresearch.com/product/pharmaceutical-contract-packaging-market-5354
Pharmaceutical Processing Equipment Market by Mode of Delivery (Oral [OSDs {Coating, Milling}, Oral Liquid Dosages {Filtration Units}], Parenterals [SIP, CIP, Process Systems], Topicals [Agitators, Homogenizers, Colloid Mills]) - Global Forecasts to 2029
https://www.meticulousresearch.com/product/pharmaceutical-processing-equipment-market-5296
Pharmaceutical Storage and Material Handling Equipment Market by Type (Transport [Conveyor, IBC], Storage, Lifting [Crane, Hoist], Stacking System [Pallet, Crate]), Operation Mode (Automatic, Manual), Product Form (Solid, Liquid) - Global Forecast to 2030
Pharmaceutical Processing and Packaging Equipment Market by Mode of Delivery (Oral, Parenteral, Topical), Secondary Packaging (Cartoning, Labelling, Serialization), and End-of-Line Packaging (Palletizing, Case Packaging) - Global Forecasts to 2028
About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.
Contact:
Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Content Source: https://www.meticulousresearch.com/pressrelease/825/europe-pharmaceutical-contract-development-and-manufacturing-market-2030
